Tag: Anticoagulants
Dabigatran Does Not Beat Aspirin for Preventing Recurrent Stroke
Efficacy similar to aspirin for preventing recurrent stroke after embolic stroke of undetermined source
ASA: Reversal Agent Cuts Severe Bleeding With Factor Xa Inhibitors
Bolus plus two-hour infusion of andexanet alfa cuts antifactor Xa activity by 92 percent
Expanded Recall of Warfarin Level Monitoring Test Strips
Inaccurate results may put patients at risk for serious injury or death
Assay Aids Anticoagulant Dosing of Obese Patients for Bariatric Sx
Thrombin generation assay may allow more accurate determination of anticoagulation adequacy
Hospitalization for Upper GI Bleed Highest With Rivaroxaban
Upper gastrointestinal bleeding hospitalization risk lower for anticoagulant tx with PPI cotherapy
Racial Disparities Seen in Use of Oral Anticoagulants for A-Fib
When treated for atrial fibrillation, quality of anticoagulant use lower in blacks, Hispanics
Net Benefit of Anticoagulants for A-Fib Varies With Stroke Rate
Benefit of warfarin anticoagulation varies with varying published stroke rates
Apixaban Is Safest Direct Oral Anticoagulant Versus Warfarin
Reduced risks of major, intracranial, and gastrointestinal bleeding compared with warfarin
Reduced-Dose Anticoagulants Feasible for Extended VTE Tx
May be as effective as full-dose direct oral anticoagulants for extended-duration treatment
Extended INR Test Intervals Safe for Warfarin-Treated Patients
Similar number of out-of-range next INR values for patients with, without extended testing interval
